Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

  • an article about a $948 million patent infringement verdict between Intel and VLSI Technology LLC;
  • another article about a Federal Circuit decision finding a generic cancer drug infringes on “Abbvie’s Pharmacyclics and Johnson & Johnson’s Janssen Biotech . . . blockbuster cancer drug Imbruvica”; and
  • a blog post about a Federal Circuit decision affirming the Patent Trial and Appeal Board’s decision “involving American National Manufacturing and Sleep Number Corp.”
Read More

Today’s Opinions – January 7, 2020

This morning the Federal Circuit issued one order granting en banc rehearing in a trade case, two precedential opinions (one en banc opinion in the trade case and one panel opinion in a patent case), and two Rule 36 summary affirmances. Here is the text of the order, the introductions to the opinions, and a list of the Rule 36 judgments.

Read More